AI company backed by Ankura introduces early access to AI-powered revenue recovery platform, led by seasoned tech and AI leaders.
Today marks the official launch of Ailevate, a new AI company designed to eliminate the friction, delays, and manual work that plague healthcare revenue cycle operations. Backed by the global consulting firm Ankura, Ailevate enters the market with a mission to redefine how claims are recovered and managed, starting with an AI workforce solution that specifically resolves coding issues in claim denials.
Each year, U.S. healthcare providers leave billions on the table due to rejected claims and underpaid reimbursements. The denial recovery process is often slow, inconsistent, and dependent on overburdened RCM teams. Ailevate aims to change that.
“We’re not building just another AI tool—we’re building a system that works like a workforce,” said Glen Pendley, President at Ailevate. “Ailevate’s platform is designed to operate behind the scenes, recovering revenue that would otherwise be lost, without adding complexity or cost to your tech stack.”
While the platform is still in early access, Ailevate is already partnering with healthcare providers to pilot the technology in real-world settings. Full general availability is expected in the coming months.
A team built for transformation
Ailevate was founded by a veteran team of operators and technologists with deep experience in AI, healthcare, and enterprise infrastructure:
Ailevate was founded by a veteran team of operators and technologists with deep experience in AI, healthcare, and enterprise infrastructure:
- Glen Pendley, President, a former U.S. Marine and veteran tech executive with over 20 years of experience, served as CTO at Tenable, where he spearheaded platform innovation and global product strategy. He’s committed to building enterprise-grade tools that solve tangible operational challenges.
- Luc Delsalle, Chief Technology Officer, a seasoned engineer and leader with over 15 years of experience scaling cross-functional teams, excels at transforming complex AI ideas into reliable, market-ready products in fast-paced environments.
- Jeff Hunter, Chief AI Officer, with 25+ years working across Wall Street, Fortune 500, and U.S. intelligence, Jeff leads the R&D team developing “neuro‑agents”—cognitive AI frameworks designed to autonomously handle complex tasks in real time.
- James Rafferty, Chief Revenue Officer, with 20 years of experience in technology sales, has a proven track record of launching and scaling GTM teams in both startup and enterprise settings, delivering solutions both directly and through channels.
- Kelsey Jensen, Chief Marketing Officer, as a marketing leader with over 15 years in the technology space, Kelsey specializes in GTM strategy, channel optimization, and strategic partnerships, having driven brand and product adoption at companies like Cisco, Parallels, and Alludo.
The company operates as a portfolio business of Ankura, a global advisory and expert services firm, enabling Ailevate to scale quickly with enterprise support, healthcare insights, and capital flexibility.
“We’re launching Ailevate because AI should do more than assist—it should act,” said Luc DelSalle, CTO. “With the right foundation, we believe AI agents can fully handle the complexity of revenue recovery and lay the groundwork for autonomous operations across the healthcare enterprise.”
Meet us at HFMA and AHA
Ailevate will be showcasing its early access platform and future roadmap at upcoming industry events, including the HFMA Annual Conference and AHA Leadership Summit. Healthcare finance leaders are invited to connect with the team, learn more about early access opportunities, and see how autonomous recovery can drive real results.
Ailevate will be showcasing its early access platform and future roadmap at upcoming industry events, including the HFMA Annual Conference and AHA Leadership Summit. Healthcare finance leaders are invited to connect with the team, learn more about early access opportunities, and see how autonomous recovery can drive real results.
About Ailevate
Ailevate builds AI agents that eliminate the manual work behind revenue recovery in healthcare. Built for scale, security, and real-world impact, the Ailevate platform operates quietly in the background to recover lost revenue, resolve denials, and reduce administrative burden—without the need for human oversight. Ailevate is backed by Ankura and led by experts in healthcare, AI, and enterprise technology.
Ailevate builds AI agents that eliminate the manual work behind revenue recovery in healthcare. Built for scale, security, and real-world impact, the Ailevate platform operates quietly in the background to recover lost revenue, resolve denials, and reduce administrative burden—without the need for human oversight. Ailevate is backed by Ankura and led by experts in healthcare, AI, and enterprise technology.
For media inquiries or early access to the platform, visit www.ailevate.com or contact marketing@ailevate.com.
⸻
⸻